VanEck Associates’s Cavium, Inc. CAVM Stock Holding History

VanEck Associates’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-208,413	Closed	-$18M	–	874
2018 Q2	$18M	Buy	208,413 +44,675	+27%	+$3.58M	0.08%	185
2018 Q1	$13M	Buy	163,738 +11,427	+8%	+$997K	0.06%	215
2017 Q4	$12.8M	Buy	152,311 +48,555	+47%	+$3.76M	0.06%	216
2017 Q3	$6.84M	Buy	103,756 +48,010	+86%	+$3.04M	0.04%	267
2017 Q2	$3.46M	Sell	55,746 -44,007	-44%	-$3.07M	0.02%	327
2017 Q1	$7.15M	Buy	99,753 +37,242	+60%	+$2.49M	0.03%	262
2016 Q4	$3.9M	Buy	62,511 +5,083	+9%	+$293K	0.02%	326
2016 Q3	$3.34M	Buy	+57,428	New	+$2.88M	0.02%	335

VanEck Associates's CAVM Position: Q3 2018 in Review

VanEck Associates sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 208,413 shares — an estimated $18M sold.

VanEck Associates first reported a position in CAVM in Q3 2016 and held it in 8 quarters. The position peaked at $18M in Q2 2018. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.

VanEck Associates reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
VanEck Associates sold 208,413 Cavium, Inc. shares in Q3 2018, an estimated $18M.
VanEck Associates first reported a position in Cavium, Inc. in Q3 2016 and held it in 8 quarters.
VanEck Associates's Cavium, Inc. position peaked at $18M in Q2 2018.
0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.

Based on VanEck Associates's 13F filing for Q3 2018, filed 13 Nov 2018.